[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:transformed-indolent-b-cell-non-hodgkin-lymphoma-to-diffuse-large-b-cell-lymphoma":3},{"name":4,"total":5,"trials":6,"biomarkers":15,"states":16},"Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07638982","Axatilimab + CAR-T for High-Risk Lymphoma",[11],"Phase 1","NOT_YET_RECRUITING","2026-08-03T03:29:32.085476Z","2026-06-14T18:39:22.257504Z",[],[]]